Home > Balance Sheet > GLAND PHARMA

GLAND PHARMA
Total Non-Current Liabilities

    Back to Balance Sheet
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Total Non-Current Liabilities ₹482 Cr₹457 Cr₹489 Cr₹90 Cr₹94 Cr

What is the latest Total Non-Current Liabilities ratio of GLAND PHARMA ?

The latest Total Non-Current Liabilities ratio of GLAND PHARMA is ₹482 Cr based on Mar2026 Consolidated results.
Year Total Non-Current Liabilities
Mar2026₹482 Cr
Mar2025₹457 Cr
Mar2024₹489 Cr
Mar2023₹90 Cr
Mar2022₹94 Cr

How is Total Non-Current Liabilities of GLAND PHARMA Trending?

Years Total Non-Current Liabilities % Change
Mar2026 ₹482 Cr
5.45
Mar2025 ₹457 Cr
-6.41
Mar2024 ₹489 Cr
444.83
Mar2023 ₹90 Cr
-4.57
Mar2022 ₹94 Cr -

Compare Total Non-Current Liabilities of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹46,536.6 Cr -3% 18.6% 43% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹456,090.0 Cr 1% -2.7% 15.7% Stock Analytics
DIVIS LABORATORIES ₹226,976.0 Cr 0.7% 17.1% 40.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹185,639.0 Cr -0.3% -3.7% 37.9% Stock Analytics
CIPLA ₹115,216.0 Cr -0.3% 2.3% -8.1% Stock Analytics
DR REDDYS LABORATORIES ₹98,074.4 Cr -1.4% 0.7% -6.2% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-3%

18.6%

43%

SENSEX

-0.6%

1%

-3.7%


You may also like the below Video Courses